Coverage



RUZURGI® (amifampridine)

10 MG TABLETS

NOW AVAILABLE TO PRESCRIBE AND COVERED

Médunik Canada is pleased to announce that Ruzurgi® (amifampridine 10 mg tablets) is now available to prescribe and is covered by:

British Columbia
Special Authorization FormsDownload
Coverage CriteriaSpecial Authority Request Amifampridine
Alberta
Special Authorization FormsDownload
Coverage CriteriaAlberta Health - Drug Benefit List (bluecross.ca)
Saskatchewan
Special Authorization Forms
Coverage CriteriaList of criteria
Manitoba
Special Authorization FormsDownload
Coverage CriteriaList of criteria
Ontario
Special Authorization FormsList of resources
Coverage Criteria
Quebec
Special Authorization FormsDownload
Coverage CriteriaView list of drugs
New Brunswick
Special Authorization FormsDownload
Coverage CriteriaDrug Plans Formulary Update
Prince Edward Island
Special Authorization FormsDownload
Coverage CriteriaList of criteria
Nova Scotia
Special Authorization FormsDownload
Coverage CriteriaList of criteria
Newfoundland & Labrador
Special Authorization FormsDownload
Coverage CriteriaBulletin

To reach our medical information service, click here

The information provided on this website is intended for use by residents of Canada for general informational and educational purposes. Certain sections of this website are intended for particular audiences, including Médunik Canada’s employees and customers, as well as members of the healthcare community and the general public.